Bio & Pharma
Bio & Pharma
S.Korea's SK Bioscience to resume domestic flu vaccine output
Jun 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm's Efinopegdutide gets Fast Track Designation from FDA
Merck, known as MSD outside the United States and Canada, announced on Monday that Efinopegdutide, a technology transferred from the South Korean ph...
Jun 13, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion to expand biosimilar portfolio to 11 by 2025
South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...
Jun 13, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung Bioepis to enhance biosimilar presence with Epysqli
FRANKFURT – Samsung Bioepis Co., a biopharmaceutical unit of South Korea’s top conglomerate Samsung, is looking to gain ground in the ra...
Jun 12, 2023 (Gmt+09:00)
3 Min read -
Bio & Pharma
Samsung Biologics, Pfizer sign $411.3 mn agreement for long-term CDMO
Samsung Biologics Co., the world’s No. 1 contract drugmaker, announced a groundbreaking strategic partnership with Pfizer on Thursday, marking...
Jun 08, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
CrystalGenomics to supply anti-osteoarthritis drug to Russia for $2 mn
South Korea's first-generation biopharma venture company CrystalGenomics Inc. on Wednesday said it received a $2 million (2.6 billion won) order fro...
Jun 08, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung Biologics to double production by 2032; eyes ADCs, M&As
BOSTON – Samsung Biologics Co., the world’s No. 1 contract drugmaker, plans to more than double its total annual production capacity to ...
Jun 07, 2023 (Gmt+09:00)
4 Min read -
Bio & Pharma
Celltrion to develop Humira biosimilar oral medication with US firm
South Korea's biopharmaceutical company Celltrion Inc. announced on Monday that it has signed a contract with the US biotech firm Rani Therapeutics ...
Jun 05, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion’s Remsima SC praised in Europe as preferred biosimilar
MILAN – South Korea's biopharmaceutical company Celltrion Inc. is known in Europe for its biosimilar products such as autoimmune disease treat...
Jun 02, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
GC Biopharma wins contract to build blood products plant in Indonesia
GC Biopharma Corp., a South Korean pharmaceutical company, announced on Thursday that it has received approval from the Indonesian Ministry of Healt...
Jun 02, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
S.Korea to bolster biotech R&D, benchmarking US' Boston
South Korea is poised to boost the biotech industry by accelerating research, education and business partnerships with the biopharmaceutical sector ...
Jun 01, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Celltrion unveils phase 1 clinical data of Actemra biosimilar in Europe
South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...
May 31, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung Bioepis gets approval to sell biosimilar in Europe
South Korea's Samsung Bioepis has received approval in Europe to sell a biosimilar of Soliris, a drug for the treatment of adult and children patien...
May 31, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
BIO USA 2023 to draw S.Korean biotech leaders, startups
More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...
May 30, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
SK Bioscience’s COVID-19 vaccine gets approval in UK
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Monday that its domestic COVID-19 vaccine, SKYCovione, has rec...
May 30, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Medtronic to buy S.Korean insulin patch maker for $738 mn
Medtronic Plc., a Dublin, Ireland-based medical device maker, is set to acquire EOFlow Co., a South Korean wearable insulin patch maker, for $738 mi...
May 26, 2023 (Gmt+09:00)
3 Min read -
Bio & Pharma
HanAll, Daewoong to develop Parkinson's treatment with US partner
South Korea's HanAll Biopharma Co. and Daewoong Pharmaceutical on Thursday said they concluded a contract with NurrOn Pharmaceuticals of the US on...
May 26, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samyang secures contract for supplying filler with Chinese company
South Korea's Samyang Holdings announced on Thursday that it has signed a partnership agreement with Hangzhou Yxintent, a Chinese medical device a...
May 25, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion gets FDA approval for Humira biosimilar CT-P17
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...
May 24, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine
South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...
May 23, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
CrystalGenomics to sell largest 20% stake to Invites Healthcare for $44 mn
CrystalGenomics Inc., South Korea’s first-generation biopharma venture company, will sell new shares worth 58 billion won ($44 million) in a b...
May 23, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Celltrion Healthcare launches Remsima SC in Brazil
South Korean biopharmaceutical company Celltrion Healthcare Co. revealed on Monday its introduction of Remsima SC, a treatment for autoimmune diseas...
May 22, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
HLB submits new drug application to FDA for Rivoceranib liver cancer drug
HLB Co. announced on May 17 that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for the approval of Rivo...
May 19, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
S.Korea's Osteonic starts sports medicine exports to Japan
South Korea's surgical and medical instruments maker Osteonic Co. on Thursday announced the start of exports of its Kinex sports medicine products t...
May 19, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Sartorius to build $600 mn Korea facilities, open to more investment
Sartorius AG, a global pharmaceutical and laboratory equipment supplier, plans to spend $600 million on its first facilities in South Korea, about s...
May 18, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
S.Korea's i-Sens buys US glucose-measuring device maker for $27 mn
South Korean maker of diabetes-related devices i-Sens Inc. on Wednesday announced its planned acquisition of AgaMatrix, an American manufacturer of ...
May 18, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
NKMax submits US subsidiary's securities report to SEC
The listing in the US of NKGen Biotech, the American subsidiary of South Korean developer of natural killer (NK) cell therapy NKMax Co., is coming i...
May 17, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
InBody to release big data-based health management solutions
South Korea's InBody Co., the global leader in analytic devices for body composition, is entering the health management solution field in 2023.Usi...
May 15, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Daewoong Pharmaceutical’s cumulative tech exports exceed $870 mn
South Korea’s Daewoong Pharmaceutical said on Friday that it had concluded three technology export agreements for new drugs and new drug candi...
May 12, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
K-Bio Lab Hub, Japan's iPark to jointly support bio startups
South Korean Ministry of SMEs and Startups announced on Friday that it has reached the previous day an agreement with Japan's iPark Institute duri...
May 12, 2023 (Gmt+09:00)
1 Min read
Hidden Champions
-
3G Technologies
Published: Sep 25, 2020
Last updated: Jul 06, 2021
-
Point Mobile
Published: Sep 14, 2021
Last updated: May 10, 2022
-
Koh Young Technology Inc
Published: Sep 21, 2020
Last updated: Jan 20, 2023
-
Buhmwoo Group
Published: Apr 21, 2021
Last updated: Jan 30, 2023
-
DCM
Published: Dec 09, 2022
Last updated: Jan 30, 2023
Future Unicorns
Latest News